La feria farmacéutica más grande de Asia regresa a Shanghái en junio de 2026

Impact · against what's priced in

The announcement of the CPHI & PMEC China 2026 trade show is a routine operational update for Informa Markets. While it confirms the scale and health of the Asian pharmaceutical sourcing market, it provides no unexpected catalysts to move the stock price.

INF.L+0.05

No priced-in read yet

In context

The event's scale, featuring 110,000 attendees and 3,600 exhibitors, demonstrates the continued growth of Informa's pharmaceutical portfolio in China, though the scheduled nature of the fair limits its immediate impact.

Read from the article alone

• biotech
• china
• INF.L
• api
• pharma
• pharmaceutical manufacturing
• shanghai
• supply chain
• trade show

Search tags